Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 29;7(4):29.
doi: 10.3390/ht7040029.

Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes

Affiliations
Review

Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes

Yee Tze Ung et al. High Throughput. .

Abstract

Cytochrome P450 (CYP) is a critical drug-metabolizing enzyme superfamily. Modulation of CYP enzyme activities has the potential to cause drug⁻drug/herb interactions. Drug⁻drug/herb interactions can lead to serious adverse drug reactions (ADRs) or drug failures. Therefore, there is a need to examine the modulatory effects of new drug entities or herbal preparations on a wide range of CYP isoforms. The classic method of quantifying CYP enzyme activities is based on high-performance liquid chromatography (HPLC), which is time- and reagent-consuming. In the past two decades, high-throughput screening methods including fluorescence-based, luminescence-based, and mass-spectrometry-based assays have been developed and widely applied to estimate CYP enzyme activities. In general, these methods are faster and use lower volume of reagents than HPLC. However, each high-throughput method has its own limitations. Investigators may make a selection of these methods based on the available equipment in the laboratory, budget, and enzyme sources supplied. Furthermore, the current high-throughput systems should look into developing a reliable automation mechanism to accomplish ultra-high-throughput screening in the near future.

Keywords: cytochrome P450; high-throughput screening; in vitro; inhibitory effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Work flow of fluorescence-based assay.
Figure 2
Figure 2
Schematic of the metabolism of the ‘blocked’ dye substrate into a fluorescent metabolite.
Figure 3
Figure 3
Work flow of luminescence-based assay.
Figure 4
Figure 4
Work flow of mass spectrometry (MS)-based assay.

Similar articles

Cited by

References

    1. Anzenbacher P., Anzenbacherová E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 2001;58:737–747. doi: 10.1007/PL00000897. - DOI - PMC - PubMed
    1. Doogue M.P., Polasek T.M. The ABCD of clinical pharmacokinetics. Ther. Adv. Drug Saf. 2013;4:5–7. doi: 10.1177/2042098612469335. - DOI - PMC - PubMed
    1. Zanger U.M., Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 2013;138:103–141. doi: 10.1016/j.pharmthera.2012.12.007. - DOI - PubMed
    1. Testa B., Pedretti A., Vistoli G. Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discov. Today. 2012;17:549–560. doi: 10.1016/j.drudis.2012.01.017. - DOI - PubMed
    1. Edwards I.R., Aronson J.K. Adverse drug reactions: Definitions, diagnosis, and management. Lancet. 2000;356:1255–1259. doi: 10.1016/S0140-6736(00)02799-9. - DOI - PubMed

LinkOut - more resources